A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential
- PMID: 3494307
- DOI: 10.1126/science.3494307
A chimeric, ligand-binding v-erbB/EGF receptor retains transforming potential
Abstract
Comparison of amino acid sequences from human epidermal growth factor (EGF) receptor and avian erythroblastosis virus erbB oncogene product suggests that v-erbB represents a truncated avian EGF receptor gene product. Although both proteins are transmembrane tyrosine kinases, the v-erbB protein lacks most of the extracellular ligand-binding domain and a 32-amino acid cytoplasmic sequence present in the human EGF receptor. To test the validity of the proposed origin of v-erbB and to investigate the functional significance of the deleted extracellular sequences, a chimeric gene encoding the extracellular and the transmembrane domain of the human EGF receptor joined to sequences coding for the cytoplasmic domain of the avian erbB oncogene product was constructed. When expressed in Rat1 fibroblasts, this reconstituted gene product (HER-erbB) was transported to the cell surface and bound EGF. Its autophosphorylation activity was stimulated by interaction with the ligand. Expression of the HER-erbB chimera led to anchorage-independent cell growth in soft agar and EGF-induced focus formation in Rat1 monolayers. Thus, it appears that v-erbB protein sequences in the chimeric receptor retain their transforming activity under the influence of the human extracellular EGF-binding domain.
Similar articles
-
Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.Mol Cell Biol. 1990 Jun;10(6):3048-55. doi: 10.1128/mcb.10.6.3048-3055.1990. Mol Cell Biol. 1990. PMID: 1971419 Free PMC article.
-
Epidermal growth factor (EGF) modulation of feline sarcoma virus fms tyrosine kinase activity, internalization, degradation, and transforming potential in an EGF receptor/v-fms chimera.J Virol. 1994 Jan;68(1):411-24. doi: 10.1128/JVI.68.1.411-424.1994. J Virol. 1994. PMID: 8254751 Free PMC article.
-
A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.EMBO J. 1989 Jan;8(1):159-66. doi: 10.1002/j.1460-2075.1989.tb03360.x. EMBO J. 1989. PMID: 2565807 Free PMC article.
-
Epidermal growth factor and its receptor.Mol Cell Endocrinol. 1987 Jun;51(3):169-86. doi: 10.1016/0303-7207(87)90027-x. Mol Cell Endocrinol. 1987. PMID: 3109978 Review.
-
Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.Cancer Treat Res. 1992;61:139-60. doi: 10.1007/978-1-4615-3500-3_7. Cancer Treat Res. 1992. PMID: 1360229 Review. No abstract available.
Cited by
-
Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph.Mol Cell Biol. 1988 Sep;8(9):3770-6. doi: 10.1128/mcb.8.9.3770-3776.1988. Mol Cell Biol. 1988. PMID: 3221865 Free PMC article.
-
An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions.EMBO J. 1987 Sep;6(9):2669-76. doi: 10.1002/j.1460-2075.1987.tb02558.x. EMBO J. 1987. PMID: 2824188 Free PMC article.
-
Evaluation of epidermal growth factor receptors in bladder tumours.Br J Cancer. 1987 Nov;56(5):533-7. doi: 10.1038/bjc.1987.238. Br J Cancer. 1987. PMID: 3426916 Free PMC article.
-
Genetic determinants of neoplastic transformation by the retroviral oncogene v-erbB.Proc Natl Acad Sci U S A. 1988 Oct;85(20):7597-601. doi: 10.1073/pnas.85.20.7597. Proc Natl Acad Sci U S A. 1988. PMID: 2902633 Free PMC article.
-
HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.EMBO J. 1989 Jan;8(1):167-73. doi: 10.1002/j.1460-2075.1989.tb03361.x. EMBO J. 1989. PMID: 2565808 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
